The global burkholderia pseudomallei infections drug market is anticipated to grow at a considerable CAGR during the forecast period. Infection caused by burkholderia pseudomallei bacterium is a rare disease and few options are available for their treatment. Government agencies and Pharma companies are keen on developing new therapy in form of biologics or biosimilars for such infections. For this, they are studying more about the characteristics and structure of the bacteria and how it reacts in different climates and regions. For instance, in Sept 2021, a Naval medical research center in the US has sent its team of research scientists to Australia to understand possible threats that can be caused by b pseudomallei bacteria in those regions.
Browse the full report description of “Global Burkholderia Pseudomallei Infections Drug Market Size, Share & Trends Analysis Report By Type (Cholinesterase Inhibitors And Memantine), And By Application (Hospital, Clinic And Other) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/patient-handling-equipment-market
Apart from this, the government wants to tackle these deadly infections which are the cause of mortality more safely and securely. They are allotting funds to pharma and research companies to gain more insight into the bacteria and its possible cure in the form of a drug. For instance, in April 2021, the Defense threat reduction agency provides funds to Bugworks research, Inc. to support its antibiotic BWC0977 which will be effective against various bacterial biothreats including b pseudomallei. Bugworks has also received funding to develop this antibiotic from CARB-X, which is a dedicated organization for the development of antibacterial products.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By type
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Janssen Pharmaceuticals, Novartis AG, Biogen, Algi Pharma AS, Bavarian Nordic A/S, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impact the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Burkholderia Pseudomallei Infections Drug Market Report by Segment
By type
By Application
Global Burkholderia Pseudomallei Infections Drug Market Report by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/burkholderia-pseudomallei-infections-drug-market